Clinical Trial Update: Evaluating Safety and Efficacy In Hepatitis C Patients After PegIntron Pen Treatment (Study P04896)

View source ↗

Summary

This terminated clinical trial (P04896) evaluated the safety and efficacy of PegIntron Pen in chronic hepatitis C patients, with results posted on 2012-01-30.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PegIntron Pen (pegylated interferon alfa-2b)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Hepatitis C | Status: TERMINATED | Results posted: 2012-01-30